U.S. federal trademark · Serial No. 75257438
pharmaceutical preparations, namely, angiogenesis inhibitor protein compositions for the treatment of diseases and biological processes that are mediated by angiogenesis, namely, cancer, macular degeneration, diabetic retinopathy, Crohn's disease, psoriasis and arthritis
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.